VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,462,000 | +46.0% | 192,000 | 0.0% | 0.17% | +42.0% |
| Q1 2018 | $3,057,000 | -23.4% | 192,000 | 0.0% | 0.12% | -22.7% |
| Q4 2017 | $3,990,000 | -34.5% | 192,000 | -54.8% | 0.15% | -29.4% |
| Q3 2017 | $6,090,000 | -18.1% | 425,000 | -1.2% | 0.22% | -21.0% |
| Q2 2017 | $7,439,000 | +251.2% | 430,000 | +124.0% | 0.28% | +236.6% |
| Q1 2017 | $2,118,000 | -24.0% | 192,000 | 0.0% | 0.08% | -31.1% |
| Q4 2016 | $2,788,000 | -40.9% | 192,000 | 0.0% | 0.12% | -34.3% |
| Q3 2016 | $4,714,000 | +21.9% | 192,000 | 0.0% | 0.18% | +14.6% |
| Q2 2016 | $3,867,000 | -6.9% | 192,000 | +21.5% | 0.16% | -10.7% |
| Q1 2016 | $4,155,000 | – | 158,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |